A detailed history of Cranbrook Wealth Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Cranbrook Wealth Management, LLC holds 131 shares of ZTS stock, worth $21,393. This represents 0.01% of its overall portfolio holdings.

Number of Shares
131
Previous 131 -0.0%
Holding current value
$21,393
Previous $22,000 13.64%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$145.54 - $178.83 $19,065 - $23,426
131 New
131 $22,000
Q1 2022

May 12, 2022

SELL
$181.39 - $234.03 $5,441 - $7,020
-30 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $5,678 - $6,290
30 New
30 $6,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Cranbrook Wealth Management, LLC Portfolio

Follow Cranbrook Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cranbrook Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cranbrook Wealth Management, LLC with notifications on news.